Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells
Authors
Keywords
-
Journal
ONCOGENE
Volume 34, Issue 20, Pages 2597-2608
Publisher
Springer Nature
Online
2014-07-16
DOI
10.1038/onc.2014.203
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circadian molecular clocks and cancer
- (2013) Fergal C. Kelleher et al. CANCER LETTERS
- Optimized Chemical Probes for REV-ERBα
- (2013) Ryan P. Trump et al. JOURNAL OF MEDICINAL CHEMISTRY
- Unknown
- (2013) Christos Savvidis et al. MOLECULAR MEDICINE
- mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6
- (2013) Francesca Nazio et al. NATURE CELL BIOLOGY
- Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy
- (2013) Estelle Woldt et al. NATURE MEDICINE
- Mammalian TIMELESS Is Involved in Period Determination and DNA Damage-Dependent Phase Advancing of the Circadian Clock
- (2013) Erik Engelen et al. PLoS One
- Monitoring autophagic flux by an improved tandem fluorescent-tagged LC3 (mTagRFP-mWasabi-LC3) reveals that high-dose rapamycin impairs autophagic flux in cancer cells
- (2012) Cuihong Zhou et al. Autophagy
- Guidelines for the use and interpretation of assays for monitoring autophagy
- (2012) Daniel J. Klionsky et al. Autophagy
- Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes
- (2012) Stefano Rossetti et al. CELL CYCLE
- Fluorine local environment: from screening to drug design
- (2012) Anna Vulpetti et al. DRUG DISCOVERY TODAY
- Rev-erb and Rev-erb coordinately protect the circadian clock and normal metabolic function
- (2012) A. Bugge et al. GENES & DEVELOPMENT
- Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists
- (2012) Laura A. Solt et al. NATURE
- Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β
- (2012) Han Cho et al. NATURE
- Structure-guided design and synthesis of P1′ position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors
- (2011) Harichandra D. Tagad et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy
- (2011) Agnieszka Checinska et al. Pigment Cell & Melanoma Research
- Identification of SR8278, a Synthetic Antagonist of the Nuclear Heme Receptor REV-ERB
- (2010) Douglas Kojetin et al. ACS Chemical Biology
- An RNA Interference Screen Identifies Metabolic Regulators NR1D1 and PBP as Novel Survival Factors for Breast Cancer Cells with the ERBB2 Signature
- (2010) A. Kourtidis et al. CANCER RESEARCH
- Synergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly(ADP-Ribose) Polymerase Inhibition, Gemcitabine, and Cisplatin
- (2010) K. Hastak et al. CANCER RESEARCH
- PER2 Controls Lipid Metabolism by Direct Regulation of PPARγ
- (2010) Benedetto Grimaldi et al. Cell Metabolism
- Regulation of Adipogenesis by Natural and Synthetic REV-ERB Ligands
- (2010) Naresh Kumar et al. ENDOCRINOLOGY
- Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis
- (2010) Jennifer S. Carew et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A high content screening assay for identifying lysosomotropic compounds
- (2010) Sashi Nadanaciva et al. TOXICOLOGY IN VITRO
- Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells
- (2009) Damià Tormo et al. CANCER CELL
- How nuclear receptors tell time
- (2009) Michèle Teboul et al. JOURNAL OF APPLIED PHYSIOLOGY
- Rev-erb-α: an integrator of circadian rhythms and metabolism
- (2009) Hélène Duez et al. JOURNAL OF APPLIED PHYSIOLOGY
- Loss of cryptochrome reduces cancer risk inp53mutant mice
- (2009) Nuri Ozturk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine
- (2008) Changkun Hu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Chromatin remodeling, metabolism and circadian clocks: The interplay of CLOCK and SIRT1
- (2008) Benedetto Grimaldi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started